Globalization of operations, production and development and transformation of the business model under the Medium-Term Management Plan
First written in FY2022-Q1. 12 of 15 entries say "Advanced", first in FY2022-Q2. Latest entry: 2026-09-10.
No other company in this theme has enough history to compare yet.
- 2026-09-10AdvancedBusiness Alliances
「Under this agreement, MANI will make an investment in Odne and the 2 companies will accelerate the global expansion of Odne’s technologies and products.」
The product portfolio strengthening and global expansion set out in Medium-Term Management Plan 2029 are progressing into a concrete partnership involving investment in an external company and cooperation in sales and manufacturing. - FY2026-H1AdvancedAnnual report
「To support further growth, the Group launched a new medium-term management plan, Medium-Term Management Plan 2029, beginning with the fiscal year ending August 2026. With a view to becoming a 100-year company, we will pursue a robust growth strategy focused on what makes MANI unique, including our commitment to being the world's best and our trade-off-based management approach, with the aim of creating corporate value.」
The Company has moved from its previous medium-term management plan to the implementation phase of the new Medium-Term Management Plan 2029, setting out a growth strategy and corporate value creation with a view to becoming a 100-year company. - FY2025ReframedAnnual report
「In the new medium-term management plan announced on 8 October 2025, the company aims to evolve into “a company trusted for providing outstanding products and solving challenges in medical settings.”… It aims to achieve sustainable growth and enhance corporate value by creating new value through inorganic initiatives, including strategic alliances and M&A.」
The strategic description has been recast from globalization of the sales, production and development functions under the previous medium-term management plan to Medium-Term Management Plan 2029, which includes solving challenges in medical settings, outstanding products, strategic alliances and M&A. - FY2025-H1ReframedAnnual report
「To achieve further growth, the group launched a medium-term management plan beginning with the fiscal year ending August 2022 and is transforming its business model by dramatically evolving and transforming the platforms supporting its sales, production and development functions, while pursuing initiatives to realize its corporate philosophy and evolve into a “truly global company.”」
The description has been reorganized from globalization of the existing sales, production and development functions to evolving and transforming the platforms supporting each function and becoming a “truly global company.” - FY2024AdvancedAnnual report
「Regarding product development with KOL physicians worldwide, the company had completed the launches by the previous fiscal year of the NiTi rotary file for dental root-canal treatment “JIZAI,” designated as a priority development product, the dental restorative material “MANI EG Composite,” and the ophthalmic vitreous forceps “MANI Micro Forceps.” During the fiscal year ending August 2024, it expanded the JIZAI product lineup and undertook other initiatives in response to KOL demand for broader and higher-quality dental root-canal treatment.」
The company has reported the completed launches of the 3 priority products under the medium-term management plan and is advancing initiatives including expansion of the JIZAI lineup, development of eyelet needles for robotic surgery, and smart-factory construction. - FY2024-Q3AdvancedAnnual report
「At its board meeting on 26 June 2024, the company resolved to establish a new sales subsidiary in the United States. It will promote locally focused sales in medically advanced countries and expand its business in the North American market.」
As a global marketing initiative under the medium-term management plan, the company resolved to establish a U.S. sales subsidiary, adding expansion into the North American market. - FY2024-Q2AdvancedAnnual report
「As a key initiative under the medium-term management plan, and with the aim of establishing a global production system, the German consolidated subsidiary MANI MEDICAL GERMANY GmbH (MMG) moved to its new headquarters and plant in September 2023 and began production. MMG will seek to expand its production capacity for dental restorative materials and promote sales expansion in Europe, the United States and Asia. In Japan, construction of the smart factory began in October 2023.」
The company has reconfirmed the global production initiatives under the medium-term management plan, including the start of production at MMG’s new headquarters and plant, the start of domestic smart-factory construction, and plans to increase MMG’s production capacity. - FY2024-Q1AdvancedAnnual report
「As a key initiative under the medium-term management plan, and with the aim of establishing a global production system, the German consolidated subsidiary MANI MEDICAL GERMANY GmbH (MMG) moved to its new headquarters and plant in September 2023 and began production. MMG will seek to expand its production capacity for dental restorative materials and promote sales expansion in Europe, the United States and Asia. In Japan, construction of the smart factory began in October 2023. The company will also expand its existing plant in Vietnam to increase production capacity and strengthen BCP.」
The company has reported multiple developments under the medium-term management plan, including MMG’s move to and start of production at its new headquarters and plant, the start of domestic smart-factory construction, and increased production capacity and stronger BCP through expansion of the Vietnam plant. - FY2023AdvancedAnnual report
「During the consolidated fiscal year, the second year of the medium-term management plan, the company advanced efforts to establish a mass-production system and strengthen marketing activities to expand sales of JIZAI, the plan’s priority product.」
In the second year of the medium-term management plan, the company is advancing multiple initiatives, including expanding JIZAI production and sales, completing the MMG headquarters plant and beginning production, starting construction of the smart factory, and establishing the Dental Business Division. - FY2023-Q3AdvancedAnnual report
「As part of its global marketing initiatives, the company established a new sales subsidiary in Malaysia in June 2023, with the aim of conducting marketing activities for Southeast Asian countries and expanding sales.」
As a global marketing initiative under the medium-term management plan, the company has reported concrete progress through the establishment of a Malaysian sales subsidiary in June 2023. - FY2023-Q2AdvancedAnnual report
「To achieve further growth, the group launched a medium-term management plan beginning with the fiscal year ending August 2022 and is transforming its business model by dramatically evolving and transforming the platforms supporting its sales, production and development functions, while steadily pursuing initiatives to realize its corporate philosophy. During the consolidated fiscal year, it strengthened mass-production and marketing efforts to expand sales of JIZAI, the NiTi rotary file and a priority product under the plan, promoted domestic sales of the vitreous forceps “MANI Micro Forceps,” and advanced the initial launch in Europe of a new dental restorative material jointly developed by the company and its German consolidated subsidiary GDF. GDF is constructing a new headquarters plant, with completion scheduled for around August 2023. In Japan, preparations are under way for construction of a smart factory aimed at establishing a global production system.」
The company is advancing multiple initiatives under the medium-term management plan, including stronger mass-production and marketing efforts for JIZAI, promotion of domestic sales of the vitreous forceps, the advance launch in Europe of dental restorative material, construction of GDF’s new headquarters plant, and preparations for construction of the domestic smart factory. - FY2023-Q1AdvancedAnnual report
「To achieve further growth, the group launched a medium-term management plan beginning with the fiscal year ending August 2022 and is transforming its business model by globalizing its sales, production and development functions, while steadily pursuing initiatives to realize its corporate philosophy. During the consolidated fiscal year, it strengthened efforts to establish a mass-production system and expand sales of JIZAI, the NiTi rotary file and a priority product under the plan, and prepared for the domestic launch of the vitreous forceps and the advance launch in Europe of dental restorative material sold under the MANI brand. GDF, the German consolidated subsidiary, is constructing a new headquarters plant, with completion scheduled for around August 2023. In Japan, the company is advancing preparations to construct a smart factory with the aim of establishing a global production system.」
The company has reported multiple concrete developments under the medium-term management plan, including stronger mass-production and marketing efforts for the NiTi rotary file, preparations for the domestic launch of the vitreous forceps, preparations for the advance launch in Europe of dental restorative material, completion of GDF’s new headquarters plant around August 2023, and preparations for smart-factory design. - FY2022-Q3AdvancedAnnual report
「To achieve further growth, the group launched a medium-term management plan beginning with the fiscal year ending August 2022 and is transforming its business model by globalizing its sales, production and development functions, while steadily pursuing initiatives to realize its corporate philosophy. During the consolidated fiscal year, it strengthened efforts to establish a mass-production system and expand sales of the NiTi rotary file, a priority product under the plan, and prepared for the domestic launch of the vitreous forceps and the advance launch in Europe of dental restorative material sold under the MANI brand. GDF, the German consolidated subsidiary, completed the acquisition of land for a new headquarters plant and began construction, with completion scheduled for around August 2023. In Japan, the company is advancing its smart-factory initiative and preparing for the design phase, with the aim of establishing a global production system.」
The company has reported concrete progress under the medium-term management plan, including regulatory approval for the vitreous forceps, mass production and marketing of the NiTi rotary file, and the start of construction of the new headquarters plant in Germany. - FY2022-Q2AdvancedAnnual report
「The company has established a mass-production system for the NiTi rotary file, a priority product under the medium-term management plan, and has advanced development of the new vitreous forceps toward a second-half launch. In addition, the German consolidated subsidiary has completed the acquisition of land for a new headquarters plant and is steadily progressing with plans for completion in the next fiscal year.」
The company has reported concrete progress under the medium-term management plan, including establishing a mass-production system for priority products, preparing for a second-half launch of a new product, and completing the acquisition of land for the new headquarters plant in Germany. - FY2022-Q1First statedAnnual report
「Against this backdrop, the group has launched a medium-term management plan beginning with the current consolidated fiscal year, under its mission of “Delivering the world’s highest quality to every corner of the world.” It is transforming its business model by globalizing its sales, production and development functions to achieve further growth, and is pursuing initiatives to realize its corporate philosophy.」
The company has disclosed for the first time its policy of launching a medium-term management plan beginning with the current consolidated fiscal year and transforming its business model by globalizing its sales, production and development functions.